A merger between the vitamin operations of both German chemical group BASF and Japan-based Takeda Chemical Industries Ltd has been approved by the British antitrust authorities.
Go deeper with GlobalData
BASF has announced the implementation of a capital expenditures program worth €600m (US$507m) in a bid to ensure that the merged company leads the vitamin sector.
The approval from the Competition Commission represented the final hurdle blocking BASF’s acquisition of Takeda’s vitamin business outside Japan. An official merger has been in the pipeline since the two companies signed a cooperation agreement at the end of last year.
